Caricamento...

PERK/ATF4-Dependent ZFAS1 Upregulation Is Associated with Sorafenib Resistance in Hepatocellular Carcinoma Cells

Sorafenib, a multi-kinase inhibitor, is the first-line treatment for advanced hepatocellular carcinoma (HCC) patients. However, this drug only provides a short improvement of patients’ overall survival, and drug resistance is commonly developed. Thus, the identification of resistant factor(s) or bio...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Mol Sci
Autori principali: Lin, Jiunn-Chang, Yang, Pei-Ming, Liu, Tsang-Pai
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8199104/
https://ncbi.nlm.nih.gov/pubmed/34072570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22115848
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !